Denosumab |
Malignant neoplasm of prostate |
Treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for nonmetastatic prostate cancer |
Vancomycin |
Other and unspecified noninfectious gastroenteritis and colitis |
Treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (betalactam-resistant) staphylococci |
Lamotrigine |
Rash and other nonspecific skin eruption |
Epilepsy and bipolar disorder |
Benzocaine |
Infective otitis externa, unspecified |
Relief of pain and reduction of inflammation |
Morphine |
Acute myocardial infarction, unspecified site; episode of care unspecified |
Relief of moderate to severe acute and chronic pain |
Orlistat |
Diabetes mellitus |
Obesity management, including weight loss and weight maintenance |
Sargramostim |
Myeloid leukemia, acute |
Prevention of neutropenia from chemotherapy |